A QSAR study on some series of sodium and potassium channel blockers

Medicinal Chemistry

Volumn 5, Issue 6, 2009, Pages 570-576

  Saini, Lakshman ^a   Gupta, S P ^a   Kumar Satuluri, V S A ^a  

^a MEERUT INSTITUTE OF ENGINEERING AND TECHNOLOGY   (India)

Author keywords

Arylimidazoles; Khellinone derivatives; Potassium channel blockers; Pyrazoles; QSAR study; Sodium channel blockers

Indexed keywords

ACONITINE; BATRACHOTOXIN; IMIDAZOLE DERIVATIVE; KHELLINONE DERIVATIVE; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL KV1.3; PYRAZOLE DERIVATIVE; SODIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG; VERATRIDINE;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; DRUG BINDING SITE; DRUG POTENCY; DRUG STRUCTURE; HUMAN; HUMAN CELL; HYDROPHOBICITY; IC 50; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SKELETAL MUSCLE;

BENZOFURANS; CELL LINE; HUMANS; IMIDAZOLES; POTASSIUM CHANNEL BLOCKERS; PYRAZOLES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; REGRESSION ANALYSIS; SODIUM CHANNEL BLOCKERS;

EID: 75749107484     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340609790170524     Document Type: Article

References (16)

1. (a) Anger, T.; Madge, D. J.; Mulla, M.; Riddall, D. Medicinal chemistry of neuronal voltage-gated sodium channel blockers. J. Med. Chem., 2001, 44, 115-137.
2. (b) Banos, J.E.; Sanchez, G.; Berrendero, F.; Maldonado, R. Neuropathic pain: some clues for future drug development. Mini Rev. Med. Chem., 2003, 3, 719-727.
3. Dimmock, J.R.; Puthucode, R.N.; Smith, J.M.; Hetherington, M.; Quall, J.W.; Pugazhenthi, U.; Lechler, T.; Stables, J.P. (Aryloxy) aryl semicarbazones and related compounds: a novel class of anticonvulsant agents possessing high activity in the maximal electroshock screen. J. Med. Chem., 1996, 39, 3984-3997.
4. Cook, N.S. The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol. Sci., 1998, 9, 21-28.
5. Robertson, D.W.; Steinberg, M.I. Potassium channel modulators: scientific applications and therapeutic promise. J. Med. Chem., 1990, 33, 1529-1541.
6. + channels: local anesthetics, antiarrhythmics and anticonvulsants. Trends Pharmacol. Sci., 1987, 8, 57-65.
7. nd ed.; Sinauer Associates, Inc., Scottland, M.A. 1992.
8. Waxman, S.G.; Cummins, T,R.; Dib-Hajj, S.; Fjell, J.; Black, J.A. Sodium channels, excitability of primary sensory neurons, and the molecular basis of pain. Muscle Nerve, 1999, 22, 1177-1187.
9. England, J.D.; Happel, L.T.; Kline, D.G.; Gamboni, F.; Thourn, C.L.; Liu, Z.P.; Levinson, S.R. Sodium channel accumulation in humans with painful neuromas. Neurology, 1996, 47, 272-276.
10. Liu, X.; Zhou, J.L.; Chung, K.; Chung, J.M. Ion channels associated with the ectopic discharges generated after segmental spinal nerve injury in the rat. Brain Res., 2001, 900, 119-127.
11. Mao, J.; Chen, L.L. Systemic lidocaine for neuropathic pain relief. Pain, 2000, 87, 7-17.
12. thed.; Elsevier Trends Journals: Cambridge, U.K. 1995, pp.66-69.
13. Yang, J.; Gharagozloo, P.; Yao, J.; Ilyin, V.I.; Carter, R.B.; Nguyen, P. Robledo, S.; Woodward, R.M.; Hogenkamp, D.J. 3-(4-phenoxyphenyl) pyrazoles: a novel class of sodium channel blockers. J. Med. Chem., 2004, 47, 1547-1552.
14. Liberatore, A.-M.; Schulz, J.; Pommier, J.; Barthelemy, M.-A.; Huchet, M.; Chabrier, P.-E.; Bigg, D. 2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators. Bioorg. Med. Chem. Lett., 2004, 14, 3521-3523.
15. Baell, J.B.; Gable, R.W; Harvey, A.J.; Toovey, N.; Herzog, T.; Hansel, W.; Wulff, H. Khellinone derivatives as blockers of voltage-gated potassium channel Kvl.3: synthesis and immunosuppressive activity. J. Med. Chem., 2004, 47, 2326-2336.
16. Gupta, S. P. QSAR studies on enzyme inhibitors. Chem. Rev., 1987, 87, 1183-1258.